Microbix Biosystems Stock Net Income
| MBX Stock | CAD 0.22 0.01 4.35% |
As of the 4th of February, Microbix Biosystems secures the Standard Deviation of 3.27, mean deviation of 2.14, and Risk Adjusted Performance of (0.02). In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Microbix Biosystems, as well as the relationship between them.
Microbix Biosystems Total Revenue |
|
Gross Profit | Profit Margin | Market Capitalization | Enterprise Value Revenue 1.4305 | Revenue |
| Last Reported | Projected for Next Year | ||
| Net Loss | -2.6 M | -2.7 M | |
| Net Loss | -2.6 M | -2.5 M | |
| Net Loss | -2.6 M | -2.5 M | |
| Net Loss | (0.01) | (0.02) | |
| Net Income Per E B T | 0.88 | 0.84 |
Microbix | Net Income |
Evaluating Microbix Biosystems's Net Income across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into Microbix Biosystems's fundamental strength.
Latest Microbix Biosystems' Net Income Growth Pattern
Below is the plot of the Net Income of Microbix Biosystems over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Microbix Biosystems financial statement analysis. It represents the amount of money remaining after all of Microbix Biosystems operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Microbix Biosystems' Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Microbix Biosystems' overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (2.25 M) | 10 Years Trend |
|
Net Income |
| Timeline |
Microbix Net Income Regression Statistics
| Arithmetic Mean | (1,202,474) | |
| Coefficient Of Variation | (252.99) | |
| Mean Deviation | 2,398,703 | |
| Median | (39,483) | |
| Standard Deviation | 3,042,089 | |
| Sample Variance | 9.3T | |
| Range | 12.1M | |
| R-Value | (0.01) | |
| Mean Square Error | 9.9T | |
| R-Squared | 0.0002 | |
| Significance | 0.96 | |
| Slope | (8,631) | |
| Total Sum of Squares | 148.1T |
Microbix Net Income History
Microbix Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Microbix Biosystems is extremely important. It helps to project a fair market value of Microbix Stock properly, considering its historical fundamentals such as Net Income. Since Microbix Biosystems' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Microbix Biosystems' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Microbix Biosystems' interrelated accounts and indicators.
Click cells to compare fundamentals
Microbix Biosystems 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Microbix Biosystems' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Microbix Biosystems.
| 11/06/2025 |
| 02/04/2026 |
If you would invest 0.00 in Microbix Biosystems on November 6, 2025 and sell it all today you would earn a total of 0.00 from holding Microbix Biosystems or generate 0.0% return on investment in Microbix Biosystems over 90 days. Microbix Biosystems is related to or competes with Resverlogix Corp, Briacell Therapeutics, Rubicon Organics, Charlottes Web, and Diagnos. Microbix Biosystems Inc., a life science company, manufactures viral and bacterial antigens and reagents for the diagnos... More
Microbix Biosystems Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Microbix Biosystems' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Microbix Biosystems upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.06) | |||
| Maximum Drawdown | 16.67 | |||
| Value At Risk | (4.35) | |||
| Potential Upside | 4.35 |
Microbix Biosystems Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Microbix Biosystems' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Microbix Biosystems' standard deviation. In reality, there are many statistical measures that can use Microbix Biosystems historical prices to predict the future Microbix Biosystems' volatility.| Risk Adjusted Performance | (0.02) | |||
| Jensen Alpha | (0.17) | |||
| Total Risk Alpha | (0.34) | |||
| Treynor Ratio | (0.42) |
Microbix Biosystems February 4, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.02) | |||
| Market Risk Adjusted Performance | (0.41) | |||
| Mean Deviation | 2.14 | |||
| Coefficient Of Variation | (2,341) | |||
| Standard Deviation | 3.27 | |||
| Variance | 10.7 | |||
| Information Ratio | (0.06) | |||
| Jensen Alpha | (0.17) | |||
| Total Risk Alpha | (0.34) | |||
| Treynor Ratio | (0.42) | |||
| Maximum Drawdown | 16.67 | |||
| Value At Risk | (4.35) | |||
| Potential Upside | 4.35 | |||
| Skewness | (0.81) | |||
| Kurtosis | 2.0 |
Microbix Biosystems Backtested Returns
Microbix Biosystems has Sharpe Ratio of -0.0462, which conveys that the firm had a -0.0462 % return per unit of risk over the last 3 months. Microbix Biosystems exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Microbix Biosystems' Risk Adjusted Performance of (0.02), standard deviation of 3.27, and Mean Deviation of 2.14 to check out the risk estimate we provide. The company secures a Beta (Market Risk) of 0.36, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, Microbix Biosystems' returns are expected to increase less than the market. However, during the bear market, the loss of holding Microbix Biosystems is expected to be smaller as well. At this point, Microbix Biosystems has a negative expected return of -0.15%. Please make sure to verify Microbix Biosystems' total risk alpha and the relationship between the potential upside and market facilitation index , to decide if Microbix Biosystems performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.21 |
Weak predictability
Microbix Biosystems has weak predictability. Overlapping area represents the amount of predictability between Microbix Biosystems time series from 6th of November 2025 to 21st of December 2025 and 21st of December 2025 to 4th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Microbix Biosystems price movement. The serial correlation of 0.21 indicates that over 21.0% of current Microbix Biosystems price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.21 | |
| Spearman Rank Test | -0.03 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Microbix Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, Microbix Biosystems reported net income of (2.25 Million). This is 100.66% lower than that of the Biotechnology sector and 103.21% lower than that of the Health Care industry. The net income for all Canada stocks is 100.39% higher than that of the company.
Microbix Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Microbix Biosystems' direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Microbix Biosystems could also be used in its relative valuation, which is a method of valuing Microbix Biosystems by comparing valuation metrics of similar companies.Microbix Biosystems is currently under evaluation in net income category among its peers.
Microbix Biosystems Current Valuation Drivers
We derive many important indicators used in calculating different scores of Microbix Biosystems from analyzing Microbix Biosystems' financial statements. These drivers represent accounts that assess Microbix Biosystems' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Microbix Biosystems' important valuation drivers and their relationship over time.
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 (projected) | ||
| Market Cap | 69.0M | 42.8M | 45.8M | 36.9M | 33.2M | 22.9M | |
| Enterprise Value | 61.4M | 37.8M | 39.2M | 31.5M | 28.4M | 24.5M |
Microbix Fundamentals
| Return On Equity | -0.0801 | ||||
| Return On Asset | -0.0261 | ||||
| Profit Margin | (0.12) % | ||||
| Operating Margin | (0.38) % | ||||
| Current Valuation | 26.59 M | ||||
| Shares Outstanding | 138.81 M | ||||
| Shares Owned By Insiders | 14.48 % | ||||
| Number Of Shares Shorted | 2.58 K | ||||
| Price To Book | 1.15 X | ||||
| Price To Sales | 1.65 X | ||||
| Revenue | 18.59 M | ||||
| Gross Profit | 9.85 M | ||||
| EBITDA | 428.23 K | ||||
| Net Income | (2.25 M) | ||||
| Cash And Equivalents | 402.12 K | ||||
| Total Debt | 6.77 M | ||||
| Debt To Equity | 0.53 % | ||||
| Current Ratio | 1.64 X | ||||
| Book Value Per Share | 0.20 X | ||||
| Cash Flow From Operations | (80.29 K) | ||||
| Short Ratio | 0.04 X | ||||
| Earnings Per Share | (0.02) X | ||||
| Target Price | 0.5 | ||||
| Beta | 0.38 | ||||
| Market Capitalization | 30.58 M | ||||
| Total Asset | 37.41 M | ||||
| Retained Earnings | (35.64 M) | ||||
| Working Capital | 20.8 M | ||||
| Net Asset | 37.41 M |
About Microbix Biosystems Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Microbix Biosystems's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Microbix Biosystems using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Microbix Biosystems based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Other Information on Investing in Microbix Stock
Microbix Biosystems financial ratios help investors to determine whether Microbix Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Microbix with respect to the benefits of owning Microbix Biosystems security.